SCHEMBL8808236

SCHEMBL8808236

COc1ccc(CCN(C)CCCOc2ccc(NC(=O)c3cccc4c(=O)c5ccccc5sc34)cc2)cc1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 2/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ CYP3A4 P08684 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ KDR P35968 2/20 0.44
▸ MAOA P21397 4/20 0.42
▸ MAOB P27338 4/20 0.42
▸ ABCG2 Q9UNQ0 3/20 0.42
▸ SMPD1 P17405 2/20 0.42
▸ LMNA P02545 2/20 0.41
▸ GAA P10253 1/20 0.41
▸ CYP2C8 P10632 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ ABCB1 P08183 2/20 0.40
▸ KCNH2 Q12809 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8807068 0.96 KCNH2 (0.44) MAPTKDM4ECYP3A4CYP2C19TP53
SCHEMBL8808363 0.93 MAOA (0.46) KDRMAOAMAOB
SCHEMBL8807015 0.92 ABCG2 (0.44) MAPTKDM4ECYP3A4CYP2C19TP53
SCHEMBL8808386 0.92 MAPT (0.45) MAPTKDM4ECYP3A4CYP2C19ABCG2
SCHEMBL8810117 0.89 MCHR1 (0.45) MAPTKDM4ETP53KDRMAOA
SCHEMBL8807986 0.88 KCNH2 (0.41) MAPTKDM4ECYP3A4CYP2C19TP53
SCHEMBL8807951 0.88 BCHE (0.45) MAPTKDM4ECYP3A4ABCG2LMNA
SCHEMBL8808371 0.87 KDR (0.46) MAPTKDM4ETP53KDRMAOA
SCHEMBL8809632 0.86 BCHE (0.44) MAPTKDM4ECYP3A4TP53MAOB
SCHEMBL8808197 0.86 ABCG2 (0.46) MAPTKDM4ETP53TDP1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5663179-A CAN SENSITIZE MULTIDRUG RESISTANT CANCER CELLS TO CHEMOTHERAPEUTIC AGENTS LABORATOIRES GLAXO SA (FR) 1997-09-02 — — US disclosed
EP-0649410-B1 ANILIDE DERIVATIVES GLAXO LAB SA (FR) 1997-05-02 — — EP disclosed
Send feedback